- The Union Health Ministry proposed immediate suspension of manufacturing licences for drugs found 'Not of Standard Quality' (NSQ) on critical parameters. - This aims to tighten pharmaceutical regulations, ensure patient safety, and crack down on substandard drug manufacturing. - Critical parameters involve serious quality defects that pose direct risks to public health and safety. - **Union Health Ministry:** The principal central government ministry responsible for formulating national health policies, family welfare programs, and regulating public health standards and pharmaceutical manufacturing in India. - **Drugs and Cosmetics Act:** India's premier legislation regulating the import, manufacture, distribution, and sale of drugs and cosmetics to ensure safety, efficacy, and standard quality. - **Central Drugs Standard Control Organization:** The national regulatory authority under the Ministry of Health and Family Welfare responsible for ensuring the safety, efficacy, and quality of drugs, medical devices, and cosmetics in India. **Introduction** The Union Health Ministry has proposed the immediate suspension of manufacturing licences for pharmaceutical products that fail to meet standard quality requirements on specified critical parameters, aiming to strengthen drug safety and regulatory enforcement in India. **Core Issue and Detailed Points** - The Union Health Ministry proposed immediate suspension of manufacturing licences for drugs found 'Not of Standard Quality' (NSQ) on critical parameters. - This aims to tighten pharmaceutical regulations, ensure patient safety, and crack down on substandard drug manufacturing. - Critical parameters involve serious quality defects that pose direct risks to public health and safety. **Key Statutory Bodies, Acts & Concepts** - **Union Health Ministry:** The principal central government ministry responsible for formulating national health policies, family welfare programs, and regulating public health standards and pharmaceutical manufacturing in India. - **Drugs and Cosmetics Act:** India's premier legislation regulating the import, manufacture, distribution, and sale of drugs and cosmetics to ensure safety, efficacy, and standard quality. - **Central Drugs Standard Control Organization:** The national regulatory authority under the Ministry of Health and Family Welfare responsible for ensuring the safety, efficacy, and quality of drugs, medical devices, and cosmetics in India.